Hiroki Kawashima Selected Research

Ustekinumab (CNTO 1275)

10/2023	Real-World Effectiveness and Risk Factors for Discontinuation of Ustekinumab in Ulcerative Colitis.
8/2023	Real-world effectiveness of ustekinumab for patients with ulcerative colitis: a systematic review and meta-analysis.
11/2022	The effects of ustekinumab on small intestinal lesions and stenotic lesions.
2/2021	Ustekinumab is effective against small bowel lesions in Crohn's disease: two case reports.
10/2020	Endoscopic Activity and Serum TNF-α Level at Baseline Are Associated With Clinical Response to Ustekinumab in Crohn's Disease Patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hiroki Kawashima Research Topics

Disease

34	Neoplasms (Cancer) 12/2023 - 01/2005
18	Pathologic Constriction (Stenosis) 03/2024 - 05/2012
15	Pancreatic Neoplasms (Pancreatic Cancer) 07/2023 - 04/2009
13	Crohn Disease (Crohn's Disease) 05/2024 - 01/2016
10	Ulcerative Colitis 12/2023 - 12/2020
8	Hemorrhage 07/2023 - 06/2010
7	Hepatocellular Carcinoma (Hepatoma) 04/2024 - 02/2020
5	Neoplasm Metastasis (Metastasis) 06/2022 - 11/2010
4	Sclerosing Cholangitis 01/2024 - 12/2020
4	Adenocarcinoma 10/2023 - 05/2019
4	Fibrosis (Cirrhosis) 06/2023 - 08/2012
4	Abdominal Pain (Pain, Abdominal) 06/2023 - 04/2017
4	Carcinoma (Carcinomatosis) 05/2021 - 04/2010
3	Colitis 05/2024 - 01/2021
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 03/2024 - 01/2023
3	Ulcer 12/2023 - 02/2021
3	Esophageal Squamous Cell Carcinoma 12/2023 - 01/2023
3	Non-alcoholic Fatty Liver Disease 12/2023 - 01/2023
3	Disease Progression 10/2023 - 10/2021
3	Stomach Neoplasms (Stomach Cancer) 10/2023 - 04/2010
3	Diarrhea 01/2023 - 02/2020
3	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 07/2022 - 01/2009
3	Cholangitis 07/2022 - 01/2013
3	Polyps 01/2020 - 12/2010
2	Body Weight (Weight, Body) 05/2024 - 01/2023
2	Dysbiosis 12/2023 - 03/2022
2	Necrosis 12/2023 - 05/2023
2	Esophageal Neoplasms (Esophageal Cancer) 10/2023 - 05/2022
2	Varicose Veins (Varicose Vein) 10/2023 - 01/2023
2	Biliary Atresia 10/2023 - 01/2023
2	Sarcopenia 07/2023 - 04/2022
2	Hepatitis C 06/2023 - 03/2021
2	Jaundice (Icterus) 05/2023 - 03/2013
2	Inflammation (Inflammations) 01/2023 - 01/2016
2	Syncope (Fainting) 09/2022 - 03/2022
2	Pancreatitis 01/2022 - 04/2017
2	Klatskin Tumor 01/2022 - 08/2018
2	Pancreatic Fistula (Pancreatic Fistulas) 01/2022 - 12/2017
2	Neuroendocrine Tumors (Neuroendocrine Tumor) 06/2021 - 10/2011
2	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 11/2020 - 01/2020
2	Pain (Aches) 01/2020 - 11/2019
2	Neoplasms, Cystic, Mucinous, and Serous 08/2018 - 03/2009
2	Cysts 03/2013 - 12/2012

Drug/Important Bio-Agent (IBA)

22	Capsules (Microcapsules)IBA 01/2022 - 01/2009
9	Gemcitabine FDA Link 02/2022 - 04/2009
6	Immune Checkpoint InhibitorsIBA 06/2023 - 06/2020
6	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2016
5	AntibodiesIBA 05/2024 - 11/2021
5	SteroidsIBA 01/2024 - 08/2012
5	Ustekinumab (CNTO 1275)FDA Link 10/2023 - 10/2020
4	Therapeutic UsesIBA 11/2022 - 01/2018
4	130-nm albumin-bound paclitaxelIBA 02/2022 - 01/2018
3	Monoclonal AntibodiesIBA 05/2024 - 04/2009
3	Interleukin-18 (Interleukin 18)IBA 05/2024 - 12/2023
3	Bevacizumab (Avastin)FDA Link 04/2024 - 01/2023
3	atezolizumabIBA 04/2024 - 01/2023
3	1-kestoseIBA 12/2023 - 01/2023
3	Indicators and Reagents (Reagents)IBA 09/2022 - 07/2012
3	LigandsIBA 01/2022 - 01/2021
3	Proteins (Proteins, Gene)FDA Link 05/2021 - 03/2013
3	Messenger RNA (mRNA)IBA 05/2021 - 01/2016
3	AntigensIBA 03/2021 - 04/2009
3	Contrast MediaIBA 04/2017 - 10/2011
2	CytokinesIBA 05/2024 - 12/2023
2	Volatile Fatty AcidsIBA 12/2023 - 02/2020
2	AcidsIBA 12/2023 - 11/2022
2	PrebioticsIBA 12/2023 - 01/2023
2	InterferonsIBA 12/2023 - 06/2023
2	Cisplatin (Platino)FDA LinkGeneric 10/2023 - 07/2017
2	AlbuminsIBA 07/2023 - 03/2021
2	CreatinineIBA 07/2023 - 09/2022
2	Antiviral Agents (Antivirals)IBA 06/2023 - 12/2021
2	lenvatinibIBA 05/2023 - 01/2023
2	Sorafenib (BAY 43-9006)FDA Link 05/2023 - 02/2020
2	Choline (Choline Chloride)IBA 01/2023 - 11/2021
2	Urea (Carbamide)FDA LinkGeneric 09/2022 - 03/2022
2	NitrogenIBA 09/2022 - 03/2022
2	GadoliniumIBA 06/2022 - 01/2022
2	tamibaroteneIBA 02/2022 - 01/2022
2	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2021 - 12/2012
2	CarbohydratesIBA 03/2021 - 12/2018
2	MucinsIBA 11/2020 - 04/2010
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2016 - 01/2009
1	InterleukinsIBA 05/2024

Therapy/Procedure

16	Therapeutics 04/2024 - 04/2009
8	Drug Therapy (Chemotherapy) 10/2023 - 09/2011
6	Endoscopes 03/2024 - 11/2019
5	Self Expandable Metallic Stents 07/2023 - 05/2013
5	Radiotherapy 07/2023 - 01/2010
5	Pancreatectomy 01/2022 - 10/2011
4	Stents 07/2023 - 05/2013
4	Surgical Instruments (Clip) 07/2023 - 05/2012
3	Neoadjuvant Therapy 10/2023 - 01/2022
3	Aftercare (After-Treatment) 06/2023 - 06/2020
2	Biological Therapy 05/2024 - 05/2014
2	Endoscopic Sphincterotomy 07/2022 - 01/2013
2	Catheters 01/2022 - 08/2018
2	Lasers (Laser) 07/2020 - 04/2017
2	Chemoradiotherapy 05/2019 - 01/2018
2	Immunotherapy 01/2018 - 04/2009